News Article Summary
Biogen Idec (BIIB) Q4 adjusted EPS USD 1.20 vs. Exp. USD 1.04
US STOCKS
- Q4 revenue USD 1.1bln vs. Exp. USD 1.13bln.
- sees 2010 adjusted EPS above USD 4.55 vs. Exp. USD 4.43
- says revenue growth in 2010 is expected to be in the mid single digits
- says expects capital expenditures in the range of USD 170-200mln for 2010
- Q4 Tysabri revenues USD 216mln vs. Exp. USD 217mln
- Q4 Avonex revenues USD 596mln vs. Exp. USD 592.3mln
Recent Headlines ...
- UK inflation expectations for year ahead rise to 2.5% in February from 2.4% in November 2009 - BOE Survey Thu, 09:30 11-03-2010
- German BGA exporters association says German exports will likely rise by 9% in 2010, imports by 7% Thu, 09:30 11-03-2010
- France's Sarkozy says will move with other countries at G20 to adopt tax on financial transactions Thu, 09:23 11-03-2010
- Volkswagen (VOW GY) says group retail sales up 26.7% to 1.02mln vehicles in Jan-Feb Thu, 09:02 11-03-2010
- ECB comments in monthly bulletin echo Trichet's March 4 remarks Thu, 09:01 11-03-2010
- ECB's Mersch sees erratic economic recovery in Euroarea, and ECB interest rates are appropriate Thu, 08:59 11-03-2010